Rinda Ubuzima

Rinda Ubuzima, a foreign-owned international nonprofit organization, operates exclusively as a sub-recipient on federal grants, delivering community health surveillance, disease detection, and risk communication capacity-building in Rwanda under USAID funding with no direct prime contract or grant awards.

Rinda Ubuzima holds three sub-grant awards totaling $968 thousand, all awarded since November 2022 and all routed through Jhpiego Corp as prime grantee. The vendor's work centers on strengthening community health surveillance infrastructure and event-based surveillance (e-CBS) for infectious diseases of pandemic or epidemic potential, paired with community engagement and risk communication (RCEE) capacity building. A November 2022 sub-award funded development of social and behavior change (SBC) materials and demand-generation activities for COVID-19 oral antiviral services (Paxlovid and Molnupiravir) across eight hospitals in Rwanda, executed between October 2022 and January 2023 in collaboration with the USAID RISE Project. Two subsequent sub-awards (December 2023 and May 2024) continued this thrust, strengthening the capacity of Community Health Programs through e-learning for community health workers and event-based surveillance of infectious disease threats at the community level, with a stated transition to a Transition Award upon completion of the Implementation and Service Delivery Award (ISDA) cycle.

All awards originate from USAID, split between USAID Rwanda (2 awards) and the USAID Bureau for Management (1 award). Activity has remained flat at one award per year. Rinda Ubuzima holds no federal contract vehicles, IDIQs, or prime contract or grant positions; the vendor's federal footprint is entirely subcontract-dependent and confined to USAID's Rwanda health security and pandemic preparedness mission set.